The immune response as a therapeutic target in non-alcoholic fatty liver disease

The immune response as a therapeutic target in non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is a complex and heterogeneous disorder considered a liver-damaging manifestation of metabolic syndrome. Its prevalence has increased in the last decades due to modern-day lifestyle factors associated with overweight and obesity, making it a relevant public...

Full description

Bibliographic Details
Main Authors: Nicolás Ortiz-López, Catalina Fuenzalida, María Soledad Dufeu, Araceli Pinto-León, Alejandro Escobar, Jaime Poniachik, Juan Pablo Roblero, Lucía Valenzuela-Pérez, Caroll J. Beltrán
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
non-alcoholic fatty liver disease (NAFLD)
microbiota-gut-liver axis
low-grade inflammation
liver lymphocyte homing
steatohepatitis (NASH)
microbiota
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.954869/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.954869/full

Similar Items